{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:21:04Z","timestamp":1794835264514,"version":"4.9.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1245\/s10434-026-20381-1","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:27:11Z","timestamp":1786202831000},"page":"11010-11017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of 2015 and 2025 ATA Risk Stratification Systems for Predicting Recurrence in Papillary Thyroid Carcinoma"],"prefix":"10.1245","volume":"33","author":[{"given":"Ji Hyun","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Ram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunju","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Eun","family":"Leem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jin","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Hyop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye In","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-2437","authenticated-orcid":false,"given":"Tae Hyuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"5","key":"20381_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/thy.2021.0662","volume":"32","author":"UC Megwalu","year":"2022","unstructured":"Megwalu UC, Moon PK. Thyroid cancer incidence and mortality trends in the United States: 2000\u20132018. Thyroid. 2022;32(5):560\u201370. https:\/\/doi.org\/10.1089\/thy.2021.0662.","journal-title":"Thyroid."},{"issue":"5","key":"20381_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338(5):297\u2013306. https:\/\/doi.org\/10.1056\/NEJM199801293380506.","journal-title":"N Engl J Med."},{"issue":"1","key":"20381_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid."},{"issue":"7","key":"20381_CR4","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1210\/jc.2015-4290","volume":"101","author":"DP Momesso","year":"2016","unstructured":"Momesso DP, Vaisman F, Yang SP, et al. Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J Clin Endocrinol Metab. 2016;101(7):2692\u2013700. https:\/\/doi.org\/10.1210\/jc.2015-4290.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"20381_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/thy.2016.0252","volume":"27","author":"SG Lee","year":"2017","unstructured":"Lee SG, Lee WK, Lee HS, et al. Practical performance of the 2015 American thyroid association guidelines for predicting tumor recurrence in patients with papillary thyroid cancer in South Korea. Thyroid. 2017;27(2):174\u201381. https:\/\/doi.org\/10.1089\/thy.2016.0252.","journal-title":"Thyroid."},{"issue":"12","key":"20381_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1089\/thy.2022.0055","volume":"32","author":"J Wu","year":"2022","unstructured":"Wu J, Hu XY, Ghaznavi S, et al. The prospective implementation of the 2015 ATA guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a Canadian tertiary care referral setting. Thyroid. 2022;32(12):1509\u201318. https:\/\/doi.org\/10.1089\/thy.2022.0055.","journal-title":"Thyroid."},{"issue":"8","key":"20381_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, et al. 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid. 2025;35(8):841\u2013985. https:\/\/doi.org\/10.1177\/10507256251363120.","journal-title":"Thyroid."},{"issue":"1","key":"20381_CR8","doi-asserted-by":"publisher","DOI":"10.1530\/EC-25-0703","volume":"15","author":"JH Yoo","year":"2026","unstructured":"Yoo JH, Kim BR, Leem DE, et al. Integrating TERT promoter mutations into risk stratification of papillary thyroid cancer. Endocr Connect. 2026;15(1):e250703. https:\/\/doi.org\/10.1530\/EC-25-0703.","journal-title":"Endocr Connect."},{"issue":"2","key":"20381_CR9","doi-asserted-by":"publisher","DOI":"10.1530\/erc-22-0293","volume":"30","author":"CC Juhlin","year":"2022","unstructured":"Juhlin CC, Mete O, Baloch ZW. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 2022;30(2):e220293. https:\/\/doi.org\/10.1530\/erc-22-0293.","journal-title":"Endocr Relat Cancer."},{"issue":"11","key":"20381_CR10","doi-asserted-by":"publisher","first-page":"R387","DOI":"10.1530\/ERC-17-0270","volume":"24","author":"J Krajewska","year":"2017","unstructured":"Krajewska J, Chmielik E, Jarz\u0105b B. Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017? Endocr Relat Cancer. 2017;24(11):R387\u2013402. https:\/\/doi.org\/10.1530\/ERC-17-0270.","journal-title":"Endocr Relat Cancer."},{"issue":"1","key":"20381_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61(1):92\u2013105. https:\/\/doi.org\/10.1111\/j.0006-341X.2005.030814.x.","journal-title":"Biometrics."},{"key":"20381_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2026.107912","volume":"175","author":"H Park","year":"2026","unstructured":"Park H, Kim BR, Yoo JH, et al. Clinical implication of the 2025 ATA risk stratification in follicular thyroid carcinoma: a comparison with the 2015 ATA risk stratification. Oral Oncol. 2026;175:107912. https:\/\/doi.org\/10.1016\/j.oraloncology.2026.107912.","journal-title":"Oral Oncol."},{"issue":"11","key":"20381_CR13","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/1097-0142(19931201)72","volume":"72","author":"GT Emerick","year":"1993","unstructured":"Emerick GT, Duh QY, Siperstein AE, Burrow GN, Clark OH. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer. 1993;72(11):3287\u201395. https:\/\/doi.org\/10.1002\/1097-0142(19931201)72.","journal-title":"Cancer."},{"issue":"5","key":"20381_CR14","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2013-3734","volume":"99","author":"M Melo","year":"2014","unstructured":"Melo M, da Rocha AG, Vinagre J, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2014;99(5):E754\u201365. https:\/\/doi.org\/10.1210\/jc.2013-3734.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"20381_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cen.12999","volume":"85","author":"M Bullock","year":"2016","unstructured":"Bullock M, Ren Y, O\u2019Neill C, et al. TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas. Clin Endocrinol. 2016;85(2):283\u201390. https:\/\/doi.org\/10.1111\/cen.12999.","journal-title":"Clin Endocrinol."},{"issue":"10","key":"20381_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1530\/erc-16-0219","volume":"23","author":"TH Kim","year":"2016","unstructured":"Kim TH, Kim YE, Ahn S, et al. TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocr Relat Cancer. 2016;23(10):813\u201323. https:\/\/doi.org\/10.1530\/erc-16-0219.","journal-title":"Endocr Relat Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20381-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:35:54Z","timestamp":1794832554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20381-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":16,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["20381"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20381-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}